TELA Bio (TELA)
NASDAQ:TELA
Total Valuation
TELA Bio has a market cap or net worth of $28.47M. The enterprise value is $33.28M.
Market Cap$28.47M
Enterprise Value$33.28M
Share Statistics
TELA Bio has 44,740,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,740,370
Owned by Insiders20.80%
Owned by Institutions51.09%
Financial Efficiency
TELA Bio’s return on equity (ROE) is -6.15 and return on invested capital (ROIC) is -53.21%.
Return on Equity (ROE)-6.15
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-53.21%
Return on Capital Employed (ROCE)-0.53
Revenue Per Employee384.09K
Profits Per Employee-185.79K
Employee Count209
Asset Turnover0.99
Inventory Turnover2.35
Valuation Ratios
The current PE Ratio of TELA Bio is ―. TELA Bio’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.69
PB Ratio8.78
Price to Fair Value8.78
Price to FCF-1.93
Price to Operating Cash Flow-1.26
PEG Ratio0.04
Income Statement
In the last 12 months, TELA Bio had revenue of 80.28M and earned -38.83M in profits. Earnings per share was -0.83.
Revenue80.28M
Gross Profit54.34M
Operating Income-33.76M
Pretax Income-38.60M
Net Income-38.83M
EBITDA-33.76M
Earnings Per Share (EPS)-0.83
Cash Flow
In the last 12 months, operating cash flow was -28.22M and capital expenditures -448.00K, giving a free cash flow of -28.67M billion.
Operating Cash Flow-28.22M
Free Cash Flow-28.67M
Free Cash Flow per Share-0.64
Dividends & Yields
TELA Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change-32.34%
50-Day Moving Average0.79
200-Day Moving Average1.31
Relative Strength Index (RSI)43.40
Average Volume (3m)90.44K
Important Dates
TELA Bio upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateMar 24, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
TELA Bio as a current ratio of 4.20, with Debt / Equity ratio of 881.56%
Current Ratio4.20
Quick Ratio3.59
Debt to Market Cap1.00
Net Debt to EBITDA-0.14
Interest Coverage Ratio-6.44
Taxes
In the past 12 months, TELA Bio has paid 230.00K in taxes.
Income Tax230.00K
Effective Tax Rate>-0.01
Enterprise Valuation
TELA Bio EV to EBITDA ratio is -1.78, with an EV/FCF ratio of -2.10.
EV to Sales0.75
EV to EBITDA-1.78
EV to Free Cash Flow-2.10
EV to Operating Cash Flow-2.13
Balance Sheet
TELA Bio has $50.84M in cash and marketable securities with $55.65M in debt, giving a net cash position of -$4.81M billion.
Cash & Marketable Securities$50.84M
Total Debt$55.65M
Net Cash-$4.81M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$0.11
Margins
Gross margin is 67.69%, with operating margin of -42.05%, and net profit margin of -48.37%.
Gross Margin67.69%
Operating Margin-42.05%
Pretax Margin-48.09%
Net Profit Margin-48.37%
EBITDA Margin-42.05%
EBIT Margin-42.05%
Analyst Forecast
The average price target for TELA Bio is $2.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$2.00
Price Target Upside170.27% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast12.24%
EPS Growth Forecast47.45%